RecruitingPhase 2NCT06855745

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

A Phase 2, Randomized, Double-blind, Multicenter Study to Assess the Safety and Efficacy of Topical Zabalafin Hydrogel Versus Vehicle in the Treatment of Participants With Mild to Moderate Atopic Dermatitis (CLEAR-AD1)

Sponsor

Alphyn Biologics

Enrollment

72 participants

Start Date

Mar 25, 2025

Study Type

INTERVENTIONAL

Conditions

atopic dermatitis (eczema)Atopic Dermatitis Eczema Atopic Dermatitis (AD)Eczema, Atopic

Summary

A Phase 2b study investigating the efficacy of zabalafin in people with mild to moderate atopic dermatitis (eczema).

Eligibility

Min Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called zabalafin for people with atopic dermatitis, atopic dermatitis (ad), and other related conditions. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 2 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGzabalafin

Active IP

Locations(12)

Canopy Clinical Northern Beaches

Brookvale, New South Wales, Australia

Momentum Clinical Research

Darlinghurst, New South Wales, Australia

Premier Specialists

Kogarah, New South Wales, Australia

St George Dermatology

Kogarah, New South Wales, Australia

Novatrials

Kotara, New South Wales, Australia

Innovate Clinical Research

Waitara, New South Wales, Australia

Canopy Clinical Wollongong

Wollongong, New South Wales, Australia

The Skin Center

Benowa, Queensland, Australia

Momentum Clinical Research

Wellers Hill, Queensland, Australia

Veracity Clinical Research

Woolloongabba, Queensland, Australia

Canopy Clinical Altona North

North Altona, Victoria, Australia

Captain Stirling Medical Centre

Nedlands, Western Australia, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06855745

Related Trials

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

NCT072629831 location

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

NCT068992041 location

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

NCT065643895 locations

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

NCT0723994710 locations

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT0680728137 locations